Anna Björkenheim et al. JACEP 2017;j.jacep

Slides:

Advertisements

Similar presentations

One year follow-up after cryoballoon isolation of the pulmonary veins in patients with paroxysmal atrial fibrillation by Yves Van Belle, Petter Janse,

Advertisements

Circ Arrhythm Electrophysiol

Michala E.F. Pedersen et al. JACEP 2017;3:

Oana Dickinson et al. JACEP 2016;2:

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Noriko Kikuchi et al. JACEP 2016;2:

(p for noninferiority = )

Revealing Characteristics of Patients at High Risk for Developing Atrial Fibrillation.

MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.

Endothelial Dysfunction in Patients With Lone AF and AF Patients With Comorbidities Compared With That in Controls Comparisons are shown among control.

Waddah Maskoun et al. JACEP 2016;2:

Konstantinos C. Siontis et al. JACEP 2016;2:

Pablo Ávila et al. JACEP 2015;1:

Shadi Al Halabi et al. JACEP 2015;1:

Junaid A.B. Zaman et al. JACEP 2017;3:

Amir Jadidi et al. JACEP 2018;4:

Nat. Rev. Cardiol. doi: /nrcardio

Ashish Shukla et al. JACEP 2015;1:41-51

Pugazhendhi Vijayaraman et al. JACEP 2015;1:

Jose C. Pachon M. et al. JACEP 2015;1:

Pablo B. Nery et al. JACEP 2016;2:

Sébastien P.J. Krul et al. JACEP 2015;1:

AFACT Trial design: Patients with long-standing atrial fibrillation were randomized to ganglion plexus ablation (n = 117) vs. control (n = 123) on top.

Dhanunjaya Lakkireddy et al. JACEP 2015;1:

Junaid A.B. Zaman et al. JACEP 2017;3:

Sigfus Gizurarson et al. JACEP 2016;2:

Junaid A.B. Zaman et al. JACEP 2017;3:

Junaid A.B. Zaman et al. JACEP 2017;j.jacep

Amir Jadidi et al. JACEP 2018;4:

Michala E.F. Pedersen et al. JACEP 2016;j.jacep

Shohreh Honarbakhsh et al. JACEP 2017;j.jacep

Stavros Stavrakis et al. JACEP 2015;1:1-13

Heiko Lehrmann et al. JACEP 2018;j.jacep

-.&- ·Af& Q 0 "i'/

Mohit K. Turagam et al. JACEP 2017;3:

Moussa Mansour et al. JACEP 2017;3:

Mu Qin et al. JACEP 2017;j.jacep

Konstantinos C. Siontis et al. JACEP 2016;2:

Øyvind H. Lie et al. JACEP 2018;j.jacep

Pouria Alipour et al. JACEP 2017;j.jacep

The procedural journey for our cohort of patients with persistent atrial fibrillation. The procedural journey for our cohort of patients with persistent.

K.R. Julian Chun et al. JACEP 2017;3:

Yoshitaka Kimura et al. JACEP 2016;2:

Vittorio Calzolari et al. JACEP 2017;3:

Anna Björkenheim et al. JACEP 2017;j.jacep

Stavros Stavrakis et al. JACEP 2015;1:1-13

Björn Redfors et al. JACEP 2017;j.jacep

Moussa Mansour et al. JACEP 2016;j.jacep

(A) Kaplan-Meier curve showing AF-free survival after a single procedure for patients grouped according to use of CT integration. (A) Kaplan-Meier curve.

Scatterplot showing the association between baseline weight and weight change at 1 year, relative to baseline for each treatment group. Scatterplot showing.

K.R. Julian Chun et al. JACEP 2017;3:

Björn Redfors et al. JACEP 2017;j.jacep

Saurabh Kumar et al. JACEP 2017;3:

Björn Redfors et al. JACEP 2017;j.jacep

Adam B. Greenbaum et al. JACEP 2015;1:

Jose C. Pachon M. et al. JACEP 2015;1:

Anna Björkenheim et al. JACEP 2017;j.jacep

Nat. Rev. Cardiol. doi: /nrcardio

Mean individual and summative SF-36 V2 scores before and 3 months after ablation. Mean individual and summative SF-36 V2 scores before and 3 months after.

Vesna Nikolova-Krstevski et al. BTS 2017;2:

Overall burden of AF associated with higher risk of thromboembolism and ischemic stroke An analysis of the KP-RHYTHM study, in patients with paroxysmal.

Shohreh Honarbakhsh et al. JACEP 2019;j.jacep

Vivek Y. Reddy et al. JACEP 2019;j.jacep

Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.

Vivek Y. Reddy et al. JACEP 2019;j.jacep

John P. Boehmer et al. JCHF 2017;5:

Forest plot of all-cause mortality (ACM) in CRT patient with AF comparing atrioventricular junction ablation (AVJA) versus no AVJA. AF, atrial fibrillation;

Temporal trends of AF hospitalisation per 100 patients with AF according to main hospitalisation causes between 2006 and *P value for increase trends

Henry Chubb et al. JACEP 2017;3:89-103

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

Anna Björkenheim et al. JACEP 2017;j.jacep.2017.04.003 Scatterplot Comparing the AF6 Sum Score Before and After Ablation (A) 6 months (r = 0.50, p < 0.001, n = 50), (B) 12 months (r = 0.38, p = 0.008, n = 44), and (C) 24 months (r = 0.28, p = 0.04, n = 49) after ablation. Patients above the line of identity had worsened and patients below the line improved scores following ablation. Atrial fibrillation burden is defined as <0.5% (blue rings) or >0.5% (green rings). Anna Björkenheim et al. JACEP 2017;j.jacep.2017.04.003 2017 The Authors